| Status | Study |
| Not yet recruiting |
Study Name: An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis Condition: Infection, Bacterial Anthrax Date: 2017-03-17 Interventions: Other: Collection of samples T |
| Active, not recruiting |
Study Name: A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects Condition: Anthrax Date: 2016-01-12 Interventions: Biological: Px563L, RPA563, or placebo Two intramuscular injections |
| Recruiting |
Study Name: Special Drug Use Investigation of Ciproxan Injection in Pediatrics Condition: Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax Date: 2015-09-18 Interventions: Drug: Cipro (Ciprofloxacin, BAYQ3939) Treatment parameters following the physician's decision based on t |
| Active, not recruiting |
Study Name: Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed Condition: Infections, Bacterial Date: 2015-01-12 Interventions: Biological: AVA Sterile, milky |
| Completed |
Study Name: PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine Condition: Anthrax Date: 2014-08-13 Interventions: Biological: PA83-FhCMB |
| Not yet recruiting |
Study Name: An Open Label, Phase IV Study Evaluating the Clinical Benefit, Safety and Pharmacokinetics of Raxibacumab in Subjects Exposed to Bacillus Anthracis Condition: Infections, Bacterial Date: 2014-05-15 Interventions: Other: Collection of samples Whenever possible serum sampl |
| Completed |
Study Name: An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection Condition: Therapeutic Treatment of Inhalation Anthrax Date: 2013-12-16 Interventions: Biological: Raxibacumab Raxibacumab will be supplied in 50 milliliter (mL) sterile, single-use vials con |
| Completed |
Study Name: A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines Condition: Anthrax Infection Date: 2013-10-16 Interventions: Biological: AVA Anthrax Vaccin |
| Completed |
Study Name: Open-Label, Randomized, Parallel Group Study to Assess the Safety, Tolerability and PK of ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers Condition: Inhalational Anthrax Date: 2013-09-20 Interventions: Biological: ETI-204 Intravenou |
| Completed |
Study Name: Safety, Tolerability, and PK of Single IM Doses of ETI-204 in Adult Volunteers Condition: Inhalational Anthrax Date: 2013-08-02 Interventions: Biological: ETI-204 monoclonal |